IFNA2 and hepatocellular carcinoma: In the present study, we tested the changes in intracellular signaling pathways and HBV replication after IFNα-2a treatment in hepatoma cells, HepG2.2.15 and Huh7 cells, which are commonly used cell models for HBV replication, and primary human hepatocytes (PHHs).